Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real‐world setting: The XENSOR Study
Gorgojo‐Martínez, Juan J., Basagoiti‐Carreño, Belen, Sanz‐Velasco, Alberto, Serrano‐Moreno, Clara, Almodóvar‐Ruiz, Francisca
Published in International journal of clinical practice (Esher) (01.11.2019)
Published in International journal of clinical practice (Esher) (01.11.2019)
Get full text
Journal Article
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Gorgojo-Martínez, Juan J, Mezquita-Raya, Pedro, Carretero-Gómez, Juana, Castro, Almudena, Cebrián-Cuenca, Ana, de Torres-Sánchez, Alejandra, García-de-Lucas, María Dolores, Núñez, Julio, Obaya, Juan Carlos, Soler, María José, Górriz, José Luis, Rubio-Herrera, Miguel Ángel
Published in Journal of clinical medicine (24.12.2022)
Published in Journal of clinical medicine (24.12.2022)
Get full text
Journal Article
Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery
Gorgojo-Martínez, Juan J., M.D, Feo-Ortega, Gara, M.D, Serrano-Moreno, Clara, M.D
Published in Surgery for obesity and related diseases (01.12.2016)
Published in Surgery for obesity and related diseases (01.12.2016)
Get full text
Journal Article
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
Castro Conde, Almudena, Marzal Martín, Domingo, Campuzano Ruiz, Raquel, Fernández Olmo, Maria Rosa, Morillas Ariño, Carlos, Gómez Doblas, Juan José, Gorriz Teruel, Jose Luis, Mazón Ramos, Pilar, García-Moll Marimon, Xavier, Soler Romeo, Maria Jose, León Jiménez, David, Arrarte Esteban, Vicente, Obaya Rebollar, Juan Carlos, Escobar Cervantes, Carlos, Gorgojo Martínez, Juan J
Published in Journal of clinical medicine (01.06.2023)
Published in Journal of clinical medicine (01.06.2023)
Get full text
Journal Article
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study
Hejjaji, Vittal, Gorgojo‐Martinez, Juan J., Tang, Fengming, Garnelo, Julia Blanco, Cooper, Andrew, Medina, Jesús, Mutiozabal, Miren Sequera, Khunti, Kamlesh, Nicolucci, Antonio, Shestakova, Marina V., Ji, Linong, Gomes, Marilia B., Watada, Hirotaka, Vora, Jiten, Malik, Ali O., Kosiborod, Mikhail, Arnold, Suzanne V.
Published in Diabetes, obesity & metabolism (01.09.2022)
Published in Diabetes, obesity & metabolism (01.09.2022)
Get full text
Journal Article
Real-world effectiveness and safety of dapagliflozin therapy added to a GLP1 receptor agonist in patients with type 2 diabetes
Gorgojo-Martínez, J.J, Serrano-Moreno, C, Sanz-Velasco, A, Feo-Ortega, G, Almodóvar-Ruiz, F
Published in Nutrition, metabolism, and cardiovascular diseases (01.02.2017)
Published in Nutrition, metabolism, and cardiovascular diseases (01.02.2017)
Get full text
Journal Article
Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study
Gorgojo-Martínez, Juan J., Gargallo-Fernández, Manuel A., Galdón Sanz-Pastor, Alba, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Wong-Cruz, Jaime
Published in Journal of clinical medicine (17.07.2020)
Published in Journal of clinical medicine (17.07.2020)
Get full text
Journal Article
Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance
Jain, Akshay B., Ali, Amar, Gorgojo Martínez, Juan J., Hramiak, Irene, Kavia, Ketan, Madsbad, Sten, Potier, Louis, Prohaska, Ben D., Strong, Jodi L., Vilsbøll, Tina
Published in International journal of clinical practice (Esher) (01.02.2021)
Published in International journal of clinical practice (Esher) (01.02.2021)
Get full text
Journal Article
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study
Gorgojo-Martinez, Juan J, Ferreira-Ocampo, Pablo José, Galdón Sanz-Pastor, Alba, Cárdenas-Salas, Jersy, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Almodóvar-Ruiz, Francisca
Published in Journal of clinical medicine (25.06.2023)
Published in Journal of clinical medicine (25.06.2023)
Get full text
Journal Article
Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study
Gorgojo-Martinez, Juan J, Brito-Sanfiel, Miguel, Antón-Bravo, Teresa, Galdón Sanz-Pastor, Alba, Wong-Cruz, Jaime, Gargallo Fernández, Manuel A
Published in Journal of clinical medicine (24.09.2022)
Published in Journal of clinical medicine (24.09.2022)
Get full text
Journal Article
Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
Duque, Natalia, Artime, Esther, Romera, Irene, Lebrec, Jeremie, Díaz, Silvia, Rubio, Miriam, Sicras-Mainar, Antoni, Carretero-Anibarro, Enrique, Mundet, Xavier, Gorgojo-Martínez, Juan J., Reviriego, Jesús
Published in Advances in therapy (01.07.2021)
Published in Advances in therapy (01.07.2021)
Get full text
Journal Article
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
González-Clemente, José M., García-Castillo, María, Gorgojo-Martínez, Juan J., Jiménez, Alberto, Llorente, Ignacio, Matute, Eduardo, Tejera, Cristina, Izarra, Aitziber, Lecube, Albert
Published in Diabetes therapy (01.07.2022)
Published in Diabetes therapy (01.07.2022)
Get full text
Journal Article
Real-World Clinical Outcomes Associated with Canagliflozin in Patients Aged 65 Years and Older with Type 2 Diabetes Mellitus in Spain: The Old Real-Wecan Study
Gargallo-Fernández, Manuel A., Sanz-Pastor, Alba Galdón, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Wong-Cruz, Jaime, Gorgojo-Martínez, Juan J.
Published in Diabetology (01.09.2021)
Published in Diabetology (01.09.2021)
Get full text
Journal Article
876-P: Effectiveness and Tolerability of Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily In Patients with Type 2 Diabetes in Real Life—The INTENSIFY Study
GORGOJO-MARTINEZ, JUAN J., FERREIRA-OCAMPO, PABLO J., GALDON-SANZ PASTOR, ALBA, CÁRDENAS-SALAS, JERSY J., ANTÓN-BRAVO, TERESA, BRITO, MIGUEL, ALMODOVAR-RUIZ, FRANCISCA
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
2049-P: Real-World Assessment of Orlistat and Liraglutide in Patients with Obesity: The XENSOR Study
GORGOJO-MARTINEZ, JUAN J., BELEN, BASAGOITI-CARREÑO, SANZ-VELASCO, ALBERTO, SERRANO-MORENO, CLARA, FRANCISCA, ALMODÓVAR-RUIZ
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
1440-P: Effects of Two Weight-Loss Medications, Liraglutide and Orlistat, on Liver Enzymes in Patients with Overweight or Obesity in a Real-World Setting
GORGOJO-MARTINEZ, JUAN J., CHICHARRO, PABLO L. LOIS, FERREIRA-OCAMPO, PABLO J., DOEJO-MARCIALES, SANDRA C., BARRA-MALIG, SOLANGE F., ALMODOVAR-RUIZ, FRANCISCA
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
1127-P: Real-World Clinical Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus: The Real-WECAN Study
GORGOJO-MARTINEZ, JUAN J., GARGALLO-FERNANDEZ, MANUEL A., GALDON, ALBA, ANTÓN-BRAVO, TERESA, BRITO-SANFIEL, MIGUEL, WONG-CRUZ, JAIME E.M.
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article